Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $13.8 million.

  • Orthopediatrics' Accumulated Expenses rose 453.82% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 453.82%. This contributed to the annual value of $13.9 million for FY2024, which is 2263.13% up from last year.
  • Per Orthopediatrics' latest filing, its Accumulated Expenses stood at $13.8 million for Q3 2025, which was up 453.82% from $13.4 million recorded in Q2 2025.
  • Orthopediatrics' Accumulated Expenses' 5-year high stood at $13.9 million during Q4 2024, with a 5-year trough of $4.4 million in Q1 2022.
  • Moreover, its 5-year median value for Accumulated Expenses was $8.2 million (2023), whereas its average is $8.8 million.
  • Per our database at Business Quant, Orthopediatrics' Accumulated Expenses plummeted by 859.79% in 2022 and then skyrocketed by 6792.7% in 2023.
  • Orthopediatrics' Accumulated Expenses (Quarter) stood at $5.4 million in 2021, then rose by 26.03% to $6.7 million in 2022, then surged by 67.93% to $11.3 million in 2023, then grew by 22.63% to $13.9 million in 2024, then dropped by 0.48% to $13.8 million in 2025.
  • Its Accumulated Expenses stands at $13.8 million for Q3 2025, versus $13.4 million for Q2 2025 and $11.3 million for Q1 2025.